Aflibercept 21mg/184microlitres solution for injection pre-filled syringes
NHS hospitals in England used £76,969,746 of indicative cost of Aflibercept 21mg/184microlitres solution for injection pre-filled syringes in the 12 months to April 2026, about 0.3% of all hospital medicines spend. That is up 134.7% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. Aflibercept 21mg/184microlitres solution for injection pre-filled syringes: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to April 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using Aflibercept 21mg/184microlitres solution for injection pre-filled syringes most
By indicative cost over the 12 months to April 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| University Hpls Of Leicester Nhs Trust | £6,388,198 |
| Somerset P/Ship Nhs Foundation Trust | £5,473,032 |
| South Tyneside And Sunderland Nhs Ft | £5,214,550 |
| Imperial College Healthcare Nhs Trust | £4,533,914 |
| Harrogate & District Foundation Trust | £4,364,254 |
| East Sussex Healthcare Nhs Trust | £3,794,396 |
| Univ Hpls Bristol Nhs Foundation Trust | £3,451,084 |
| United Lincolnshire Hospitals Nhs Trust | £3,045,896 |
| Aintree University Hospital Nhs Ft | £2,069,852 |
| York Teaching Hospital Nhs Ft | £2,025,940 |
The primary-care picture
No confident match to a community-dispensed medicine was found for this product, so no primary-care comparison is shown. SCMD products are recorded at product level, which does not always map cleanly to a BNF substance.